<i>POLE</i> Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

Inge C. van Gool, Florine A. Eggink, Luke Freeman-Mills, +14

Clinical Cancer Research

A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer

Hagma H. Workel, Joyce M. Lubbers, Roland Arnold, +16

Cancer Immunology Research

CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma

Hagma H. Workel, Fenne L. Komdeur, Maartje C.A. Wouters, +13

European Journal of Cancer

Endometrial AdenocarcinomaCancer ImmunosurveillanceOncologyMedicineImmunology +6

Immunological profiling of molecularly classified high-risk endometrial cancers identifies <i>POLE</i>-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

Florine A. Eggink, Inge C. van Gool, Alexandra Léary, +11

OncoImmunology

CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy

Fenne L. Komdeur, Maartje C.A. Wouters, Hagma H. Workel, +16

Oncotarget

Checkpoint InhibitionLymphocyte DevelopmentT-regulatory CellImmunologyImmune Regulation +21

Improved outcomes due to changes in organization of care for patients with ovarian cancer in the Netherlands

Florine A. Eggink, Constantijne H. Mom, Roy F.P.M. Kruitwagen, +7

Gynecologic Oncology

NursingPrimary CareMedicineCancer ManagementGynecology +7

Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study

Willem Jan van Weelden, Casper Reijnen, Florine A. Eggink, +5

European Journal of Cancer

Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome

Kim L. Brunekreeft, Sterre T. Paijens, Maartje C.A. Wouters, +13

OncoImmunology

Epithelial Ovarian CancerT-regulatory CellDeep Immune ProfilingImmunologyImmunoediting +17

207 POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer

I. Van Gool, Florine A. Eggink, Luke Freeman-Mills, +14

European Journal of Cancer

MedicineImmunologyTumor ImmunityPathologyImmune Surveillance +7

Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition

Florine A. Eggink, Inge C. van Gool, Alexandra Léary, +11

Data Archiving and Networked Services (DANS)